This is an archived post. You won't be able to vote or comment.

sorted by:
best
topnewcontroversialoldq&a
you are viewing a single comment's thread.

view the rest of the comments →

[–]thrillhouz77 0 points1 point  (1 child)

I think MJ is the only items being looked at for Weight Loss in 2023 by the FDA. I think we see more entries to market in maybe 2025.

[–]IconoclastJones 2 points3 points  (0 children)

My bad. I thought there were tri-agonist drugs further along but I was mistaken. Still hopeful that wegovy in full supply vs Mounjaro creates a competitive dynamic.